Login / Signup

Enantioselective Biocatalytic Reduction of 2 H-1,4-Benzoxazines Using Imine Reductases.

Nadine ZumbrägelPaul MachuiJannis NonnhoffHarald Gröger
Published in: The Journal of organic chemistry (2019)
A biocatalytic reduction of 2 H-1,4-benzoxazines using imine reductases is reported. This process enables a smooth and enantioselective synthesis of the resulting cyclic amines under mild conditions in aqueous media by means of a catalytic amount of the cofactor NADPH as hydride source as well as glucose as the reducing agent used in stoichiometric amounts for in situ cofactor recycling. Several substrates were studied, and the 3,4-dihydro-2 H-1,4-benzoxazines were obtained with up to 99% ee. In addition, the efficiency of this reduction process based on imine reductases as catalysts has been demonstrated for one 2 H-1,4-benzoxazine on an elevated laboratory scale running at a substrate loading of 10 g L-1 in the presence of a tailor-made whole-cell catalyst.
Keyphrases
  • highly efficient
  • ionic liquid
  • cell therapy
  • room temperature
  • blood glucose
  • blood pressure
  • adipose tissue
  • gold nanoparticles
  • insulin resistance
  • reactive oxygen species
  • crystal structure